Marion Pouillard joined Gilde Healthcare in 2023 and is investigating both private and publicly traded companies. She is involved in deal sourcing, due diligence and portfolio management.

Prior to joining Gilde Healthcare, Marion worked as an Associate at Kurma Partners – BioFund III, where she participated in the creation of Corteria Pharmaceuticals and Vico Therapeutics, and the closing of IO Biotech, Step Pharma and Lucine. During her time at Kurma she joined the board of Imcheck Therapeutics and Amolyt Pharma.

Marion has a double MSc in Biology from the European Magister of Genetics (France) and Milano-Bicocca University (Italy) and graduated from ESCP Management School with a major in Biopharmaceutical Management.

She is a French citizen based in Gilde’s Utrecht office.